Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: Reversibility with oral L-arginine but not vitamin C

Journal of the American College of Cardiology

Volumn 29, Issue 3, 1997, Pages 491-497

  Adams, Mark R ^a,c   Jessup, Wendy ^b,c   Celermajer, David S ^a,b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASCORBIC ACID;

ARTICLE; ATHEROGENESIS; CELL ADHESION; CELL CULTURE; CIGARETTE SMOKING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSCOPY; MONOCYTE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ARGININE; ASCORBIC ACID; CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MONOCYTES; SMOKING;

EID: 0031051123     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00537-2     Document Type: Article

References (51)

1. Fielding JE. Smoking: health effects and control. N Engl J Med 1985;313: 491-8.
2. Murohara T, Kugiyami K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 1994;266:H874-80.
3. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149-55.
4. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-4.
5. Kalra VK, Ying Y, Deemer K, Natarajan R, Nadler JL, Coates TD. Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 1994;160:154-62.
6. Dovgan PS, Edward JD, Zhan X, Wilde M, Agrawal DK. Cigarette smoking increases monocyte adherence to cultured endothelial cell monlayer. Biochem Biophys Res Commun 1994;203:929-34.
7. Brown AJ. Acute effects of smoking cessation on antioxidant status. J Nutr Biochem. In press.
8. Frei B, England M, Ames B. Ascorbate is an outstanding anti-oxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-81.
9. Williams RJ, Motteram JM, Sharp CH, Gallagher PJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992;94:153-9.
10. Lehr HA, Frei B, Arfors KE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA 1994;91:7688-92.
11. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992;90:1168-72.
12. Böger RH, Bode-Böger SM, Mügge A, et al. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995;117:273-84.
13. Tsao PS, Theilmeier G, Singer AH, Leung LK, Cooke JP. L-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb 1994;14:1529-33.
14. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89:2176-82.
15. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
16. Clarkson P, Adams MR, Powe AJ, et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 1996;97:1989-94.
17. Drexler H, Zeiher AM, Meisner K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991;338:1546-50.
18. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol 1995;26:1054-61.
19. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. Feyerabend C, Russell MAH. A rapid gas-liquid chromatographic method for determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 1990;42:450-2.
21. Minter AJ, Dawes J, Chesterman CN. Effects of heparin and endothelial growth supplement on hemostatic functions of vascular endothelium. Thromb Haemost 1992;67:718-23.
22. Garner B, Dean RT, Jessup W. Human macrophage-mediated oxidation of low-density lipoprotein is delayed and independent of superoxide production. Biochem J 1994;301:421-8.
23. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-2.
24. Ross R. The pathogenesis of atherosclerosis; a perspective for the 1990's. Nature 1993;362:801-9.
25. Strong JP, Malcom GT, Oalmann MC. Environmental and genetic risk factors in early human atherogenesis: lessons from the PDAY study. Pathobiological Determinants of Atherosclerosis in Youth. Pathol-Int 1995; 45:403-8.
26. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
27. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 1993;21:225-32.
28. Herderschee D, Hijdra A, Algra A, Koudstaal PJ, Kappelle LJ, van Gijn J. Silent stroke in patients with transient ischemic attack or minor ischemic stroke: the Dutch TIA Trial Study Group. Stroke 1992;23:1220-4.
29. Wynder E, Hoffmann D. Tobacco and Tobacco Smoke. New York: Academic Press, 1967.
30. Pittilo RM, Clarke JM, Harris D, et al. Cigarette smoking and platelet adhesion. Br J Haematol 1984;58:627-32.
31. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996;93:1488-92.
32. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study. Am Heart J 1987;113:1006-10.
33. Kimura S, Nishinaga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994;128:7-11.
34. Asmussen I, Kjeldsen K. Intimai ultrastructure of human umbilical arteries: observations on arteries from newborn children of smoking and non-smoking mothers. Circ Res 1975;36:579-89.
35. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 1985;37:529-33.
36. Blann AD, McCollum CN. Adverse influence of cigarette smoking on the endothelium. Thromb Haemostas 1993;70:707-11.
37. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-9.
38. De Caterina R, Libby P, Peng H-B, et al. Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest 1995;96:60-8.
39. Anderson R, Theron AJ, Richards GA, Myer MS, van Rensberg AJ. Passive smoking sensitizes circulating neutrophils. Am Rev Respir Dis 1991;144: 570-4.
40. Sun YP, Zhu BQ, Sievers RE, Glantz SA, Deedwania PC, Parmley WW. L-arginine preserves endothelial dependent relaxation during environmental tobacco smoke in lipid fed rabbits [abstract]. Circulation 1994;90 Suppl I:I-459.
41. Philis-Tsimikas A, Witztum JL. L-Arginine may inhibit atherosclerosis through inhibition of LDL oxidation [abstract]. Circulation 1995;92 Suppl I:I-422.
42. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994;24:1591-601.
43. Imaizumi T, Satoh K, Yoshida H, Kawamura Y, Hiramoto M, Takamatsu S. Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins. Atherosclerosis 1991;87:47-55.
44. Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1989;64:111-26.
45. Kallner AB, Hartmann D, Hornig DH. On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr 1981;34:1347-55.
46. Wood KM, Cadogan MD, Ramshaw AL, Parums DV. The distribution of adhesion molecules in human atherosclerosis. Histopathology 1993;22:437-44.
47. Duplaa C, Couffinhal T, Labat L, et al. Monocyte adherence to endothelial cells in patients with atherosclerosis: relationship with risk factors. Eur J Clin Invest 1993;23:474-9.
48. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107-13.
49. O'Brien KD, Allen MD, McDonald TO, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993;92:945-51.
50. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vase Biol 1995;15:1079-87.
51. Kwiterovich PO Jr. Diagnosis and management of familial dyslipoproteinemia in children and adolescents: current issues in paediatric and adolescent endocrinology. Pediatr Clin North Am 1990;37:1489-532.